Here is the latest shareholding Pattern of SUN PHARMA. For more details, see the SUN PHARMA financial fact sheet and SUN PHARMA share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Jun-22 |
3
Sep-22 |
3
Dec-22 |
3
Mar-23 |
3
Jun-23 |
3
Sep-23 |
3
Dec-23 |
3
Mar-24 |
||
---|---|---|---|---|---|---|---|---|---|---|
Indian Promoters | % | 54.48 | 54.48 | 54.48 | 54.48 | 54.48 | 54.48 | 54.48 | 54.48 | |
Foreign Promoters | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Promoters | % | 54.48 | 54.48 | 54.48 | 54.48 | 54.48 | 54.48 | 54.48 | 54.48 | |
Mutual Funds | % | 11.84 | 12.22 | 12.46 | 12.91 | 13.16 | 13.07 | 12.93 | 12.21 | |
Financial institution/Banks/Insurance | % | 7.74 | 6.53 | 5.69 | 5.23 | 5.27 | 5.16 | 5.09 | 5.12 | |
Government | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
FII | % | 14.95 | 15.99 | 16.87 | 16.88 | 16.48 | 16.78 | 17.08 | 17.72 | |
Other | % | 0.08 | 0.89 | 0.99 | 1.10 | 1.32 | 1.43 | 1.49 | 1.49 | |
Total Institution | % | 34.61 | 35.63 | 36.01 | 36.12 | 36.23 | 36.44 | 36.59 | 36.54 | |
Bodies Corporate | % | 2.90 | 2.31 | 2.31 | 2.28 | 2.25 | 2.15 | 2.14 | 2.09 | |
Individuals | % | 6.31 | 5.91 | 5.76 | 5.70 | 5.65 | 5.55 | 5.41 | 5.44 | |
NRIs/OCBs | % | 0.31 | 0.30 | 0.28 | 0.29 | 0.27 | 0.29 | 0.29 | 0.29 | |
ADR/GDR | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Others | % | 1.39 | 1.36 | 1.16 | 1.14 | 1.12 | 1.08 | 1.08 | 1.15 | |
Total Non-Institution | % | 10.91 | 9.88 | 9.51 | 9.41 | 9.29 | 9.07 | 8.92 | 8.97 | |
Total Public | % | 46.00 | 46.00 | 46.00 | 46.00 | 46.00 | 46.00 | 46.00 | 46.00 | |
Grand Total | % | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |
Pledged Promoter Holding | % | 4.04 | 2.53 | 1.92 | 1.78 | 2.29 | 2.44 | 2.44 | 2.05 | |
Subscriber Feature |
More Pharmaceuticals Company Shareholding Pattern: ZYDUS LIFESCIENCES CIPLA DIVIS LABORATORIES DR. REDDYS LAB MANKIND PHARMA
Japan's Nikkei 225 led gains in Asia as markets in the region rose across the board, following Wall Street's continued rally for a second straight day.